www.online-silver-colloidal.com
Home| Contact Us| Links

colloidalsilvermigraine - online silver colloidal

Our tech support is the best in the industry by phone or e-mail, We have the largest supply of online medicine available, you have a disease or a illness we have a helpful method and offer our products at very affordable prices.

Links
colloidalsilvermigraines
colloidalsilvertherapies
colloidalsilvertherapy
Other Links

A recent study in Japan indicates that B12 treatment helps in the growth and division of certain immune system cells.11 These cells function to prevent the immune system from over-reacting to allergens such as animals, mold, dust, and pollen. They are called suppressor cells or CD8+ lymphocytes. They “put the brakes on the immune system”. this medicationTM is a 21-day treatment of B12 lozenges sucked on twice daily. this medicationTM may help patients with hay colloidalsilvermigraine fever by providing the colloidalsilvermigraine patient’s suppressor cells with the sustained and elevated blood B12 level they need to grow and divide. It appears that by helping the immune system to become what it is genetically capable of becoming, this medicationTM turns at least some allergic people into non-allergic or moderately-allergic people.

All of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the placebo controls reported either no change or a worsening of symptoms. colloidalsilvermigraine Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion and runny nose; and p = .005 for IgE reductions. colloidalsilvermigraine In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. colloidalsilvermigraine The FDA panel acknowledged the safety of the treatment. The panel seemed to be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four of the five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6